Search results
7 Underappreciated Stocks With 25% Return Potential in 2024
InvestorPlace· 5 days agoWhether investors refer to them as undervalued or hidden gems, underappreciated stocks are always...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Pharmaceutical Technology via Yahoo Finance· 7 days agoThis potentially causes membrane damage in cancer cells, leading to selective necrosis of cancer...
Cancer biotech lays off more employees in 2024, begins hunt for 'strategic options' - Boston...
The Business Journals· 5 days agoFor the second time this year, Ikena Oncology is once again cutting its workforce and slimming down...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 7 days agoMeanwhile, an Investigator-led trial of AztraZeneca’s Lynparza was suspended and Bristol Myers...
ASCO24: Tagrisso in the spotlight, Caribou’s adjustment and Lilly’s KRAS competitor
BioPharma Dive via Yahoo Finance· 11 hours agoAstraZeneca’s targeted therapy could see wider use after ASCO data. Elsewhere, Caribou sought to...
Market Today: Prothena's Licensing Deal with Bristol Myers and E
Guru Focus· 6 days agoMarket Overview The stock market exhibited mixed action today. There wasn't a lot of conviction from...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoCIMB raises Supermax’s target price to MYR0.96 from MYR0.85 while maintaining a hold rating on the stock. Shares are 1.6% lower at MYR0.91....
The Lash Group Notifies Consumers of Massive Data Breach Leaking Their Sensitive Medical Information...
JD Supra· 7 days agoRecently, the Lash Group, a division of Cencora (formerly AmerisourceBergen) filed a series of notices with various state attorney general offices after discovering that an unauthorized party ...
Novartis leukemia drug more effective than older treatments in trial
Reuters· 4 days ago, opens new tab said patients with a type of leukemia who took its Scemblix had a significantly...
Bill honoring murder victim Amanda Dabrowski moves one step closer to law
Worcester Telegram & Gazette via Yahoo News· 5 days agoUnable to return to work due to her injuries, Dabrowski quickly lost her job at Bristol-Myers Squibb...